Clinical Trial Update: Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update on optimizing withdrawal strategy of infliximab for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Chiba University | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED